Pamiparib Combined With Surufatinib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer
Clinical trial NCT05652283 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05652283
- Sponsor
- Bai-Rong Xia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-06
- Primary completion
- 2024-05-31
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.